全文获取类型
收费全文 | 1878篇 |
免费 | 119篇 |
国内免费 | 3篇 |
出版年
2023年 | 7篇 |
2022年 | 8篇 |
2021年 | 51篇 |
2020年 | 26篇 |
2019年 | 53篇 |
2018年 | 59篇 |
2017年 | 38篇 |
2016年 | 71篇 |
2015年 | 113篇 |
2014年 | 116篇 |
2013年 | 140篇 |
2012年 | 159篇 |
2011年 | 167篇 |
2010年 | 103篇 |
2009年 | 100篇 |
2008年 | 144篇 |
2007年 | 117篇 |
2006年 | 94篇 |
2005年 | 83篇 |
2004年 | 75篇 |
2003年 | 78篇 |
2002年 | 51篇 |
2001年 | 25篇 |
2000年 | 19篇 |
1999年 | 20篇 |
1998年 | 11篇 |
1997年 | 6篇 |
1996年 | 14篇 |
1995年 | 3篇 |
1994年 | 8篇 |
1992年 | 3篇 |
1991年 | 4篇 |
1990年 | 4篇 |
1989年 | 1篇 |
1988年 | 2篇 |
1986年 | 2篇 |
1985年 | 4篇 |
1984年 | 1篇 |
1983年 | 3篇 |
1982年 | 3篇 |
1981年 | 2篇 |
1979年 | 1篇 |
1978年 | 2篇 |
1976年 | 1篇 |
1975年 | 1篇 |
1974年 | 1篇 |
1973年 | 1篇 |
1972年 | 1篇 |
1966年 | 1篇 |
1965年 | 1篇 |
排序方式: 共有2000条查询结果,搜索用时 31 毫秒
41.
Hyun Jung Koo Myoungsun Lee Jin Kim Chul Woong Woo Seong-Yun Jeong Eun Kyung Choi Namkug Kim Jin Seong Lee 《PloS one》2016,11(2)
Purpose
We assessed the effects of anti-angiogenic therapy (AAT) on radiation therapy (RT), evaluating the tumor growth and perfusion patterns on dynamic contrast enhanced MR (DCE-MR) images.Methods
Thirteen nude mice with heterotopic xenograft cancer of human lung cancer cell line were used. To observe the interval change of the tumor size and demonstrate the time-signal intensity enhancement curve of the tumor, the mice were subdivided into four groups: control (n = 2), AAT (n = 2), RT (n = 5), and combined therapy (AART, n = 4). DCE-MR images were taken four weeks after treatment. Perfusion parameters were obtained based on the Brix model. To compare the interval size changes in the RT group with those in the AART group, repeated measures ANOVA was used. Perfusion parameters in both the RT and AART groups were compared using a Mann-Whitney U test.Results
Tumor growth was more suppressed in AART group than in the other groups. Control group showed the rapid wash-in and wash-out pattern on DCE-MR images. In contrast to RT group with delayed and prolonged enhancement, both AAT and AART groups showed the rapid wash-in and plateau pattern. The signal intensity in the plateau/time to peak enhancement (P<0.016) and the maximum enhancement ratio (P<0.016) of AART group were higher than those of RT group.Conclusions
AART showed synergistic effects in anticancer treatment. The pattern of the time-intensity curve on the DCE-MR images in each group implies that AAT might help maintain the perfusion in the cancer of AART group. 相似文献42.
Koung Jin Suh June-Won Cheong Inho Kim Hyeoung-Joon Kim Dong-Yeop Shin Youngil Koh Sung-Soo Yoon Yoo Hong Min Jae-Sook Ahn Yeo-Kyeoung Kim Yun-Gyoo Lee Jeong-Ok Lee Soo-Mee Bang Yeung-Chul Mun Chu-Myoung Seong Yong Park Byung-Soo Kim Junshik Hong Jinny Park Jae Hoon Lee Sung-Yong Kim Hong Ghi Lee 《PloS one》2016,11(11)
Chromosomal translocations are rare in myelodysplastic syndrome (MDS) and their impact on overall survival (OS) and response to hypomethylating agents (HMA) is unknown. The prognostic impact of the revised International Prognostic Scoring System (IPSS-R) and for chromosomal translocations was assessed in 751 patients from the Korea MDS Registry. IPSS-R effectively discriminated patients according to leukaemia evolution risk and OS. We identified 40 patients (5.3%) carrying translocations, 30 (75%) of whom also fulfilled complex karyotype criteria. Translocation presence was associated with a shorter OS (median, 12.0 versus 79.7 months, P < 0.01). Multivariate analysis demonstrated that translocations (hazard ratio [HR] 1.64 [1.06–2.63]; P = 0.03) as well as age, sex, IPSS-R, and CK were independent predictors of OS. In the IPSS-R high and very high risk subgroup (n = 260), translocations remained independently associated with OS (HR 1.68 [1.06–2.69], P = 0.03) whereas HMA treatment was not associated with improved survival (median OS, 20.9 versus 21.2 months, P = 0.43). However, translocation carriers exhibited enhanced survival following HMA treatment (median 2.1 versus 12.4 months, P = 0.03). Our data suggest that chromosomal translocation is an independent predictor of adverse outcome and has an additional prognostic value in discriminating patients with MDS having higher risk IPSS-R who could benefit from HMA treatment. 相似文献
43.
44.
Kyung Sun Park Jongha Park Seong Hoon Choi Seo Hee Ann Gillian Balbir Singh Eun-Seok Shin Jong Soo Lee Hyun Chul Chung 《PloS one》2016,11(3)
Serum phosphorus (P) concentration is associated with coronary artery calcification (CAC) as well as cardiovascular events in patients with chronic kidney disease. It has been suggested that this relationship is extended to subjects without renal dysfunction, but further explorations in diverse races and regions are still needed. We performed a cross-sectional study of 2,509 Korean subjects (Far Eastern Asian) with an estimated glomerular filtration rate of ≥60 ml/min/1.73m2 and who underwent coronary computerized tomography. Serum P concentration was divided into pre-determined 4 categories: ≤3.2, 3.2< to ≤3.6, 3.6< to ≤4.0 and >4.0 mg/dL. Agatston score (AS), an index of CAC, was divided into 3 categories: 0, 0< to ≤100, and >100. A multinomial logit model (baseline outcome: AS = 0) was applied to estimate the odds ratio (OR) for each serum P category (reference: ≤3.2mg/dL). Mean age of subjects was 53.5±9.1 years and 36.9% were female. In the adjusted model, serum P concentration of 3.6< to ≤4.0 mg/dL and >4.0 mg/dL showed high ORs for AS of >100 [OR: 1.58, 95% confidence interval (CI): 1.04–2.40 and OR: 2.11, 95% CI: 1.34–3.32, respectively]. A unit (mg/dL) increase in serum P concentration was associated with 50% increase in risk of AS >100 (OR: 1.50, 95% CI: 1.16–1.94). A higher serum P concentration, even within a normal range, may be associated with a higher CAC in subjects with normal renal function. 相似文献
45.
46.
47.
48.
49.
50.